Pragna Rao

Pragna Rao

Auto-generated profile, based on publicly available information

Pragna Rao

Department of Biochemistry, Kasturba Medical College, Manipal University, Manipal, Karnataka, India

Research Focus & Metrics

Academic Career Length

39Years (1988-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 1989 in Analytical Biochemistry
Verified
Journal Article
Closed access
PRPragna Rao
Pragna Rao
TPThillaisthanam N. Pattabiraman
Thillaisthanam N. Pattabiraman

1 January 2019 in Diabetes & Metabolic Syndrome: Clinical Research & Reviews
Verified
Journal Article
Closed access
Imran Ali KhanImran Ali Khan
Imran Ali Khan
PJParveen Jahan
Parveen Jahan
QHQurratulain Hasan
Qurratulain Hasan
PRPragna Rao
Pragna Rao

8 December 2012 in Endocrine
Verified
Journal Article
Closed access
PDF file
AHA. Haribabu
A. Haribabu
VRVarikasuvu Seshadri Reddy
Varikasuvu Seshadri Reddy
CPCh. Pallavi
Ch. Pallavi
ABAparna R. Bitla
Aparna R. Bitla
ASAlok Sachan
Alok Sachan
MSM. M. Suchitra
M. M. Suchitra

1 December 2014 in Meta Gene
Verified
Journal Article
Open access
Imran Ali KhanImran Ali Khan
Imran Ali Khan
SMSireesha Movva
Sireesha Movva
NSNoor Ahmad Shaik
Noor Ahmad Shaik
SCSrinivas Chava
Srinivas Chava
PJParveen Jahan
Parveen Jahan
PRPragna Rao
Pragna Rao
Type 2 Diabetes Mellitus (T2DM) and Gestational Diabetes Mellitus (GDM) are part of a heterogeneous and complex metabolic group of disorders that share common pathophysiological circumstances, including β-cell dysfunction and insulin resistance. The protein Calpain 10 (CAPN10) plays a role in glucose metabolism, pancreatic β-cell insulin secretion, and thermogenesis. Polymerase Chain Reaction-Restriction Fragment Length Polymorphism (PCR-RFLP) based genotyping of CAPN10 (rs2975760) polymorphism was carried out in T2DM and GDM with suitable controls for each of the pathologies from the same population. Genomic DNA was isolated from 787 participants, including 250 cases of T2DM, 287 pregnant women, of which 137 were identified as having GDM and the remaining 150 were confirmed as non-GDM, and 250 healthy control volunteers, and association analysis was carried out for genotypes and alleles. In the present study, T2DM was compared with healthy controls and was not found to be associated with the CAPN10 C allele (odds ratio, OR: 1.09; 95% CI = 0.8011-1.484; p = 0.5821). GDM also did not show any association when compared with non-GDM (OR: 1.124; 95% CI = 0.7585-1.667; p = 0.5606) respectively. Our study suggests that the CAPN10 (rs2975760) polymorphism scrutinized in this study is not associated with T2DM and GDM.

27 May 2014 in International Journal of Neuroscience
Verified
Journal Article
Closed access
PDF file
SDSambit Dash
Sambit Dash
APAparna R. Pai
Aparna R. Pai
UKUllas Kamath
Ullas Kamath
PRPragna Rao
Pragna Rao
Guillain–Barré syndrome (GBS) is an autoimmune polyneuropathy which presents with acute onset and rapid progression of flaccid, hyporeflexi quadriparesis. Both sensory and autonomic nerve involvement is seen. GBS has various subtypes that vary in their pathophysiology. The pathogenesis involves an immune response triggered by a preceding event which may be an infection, immunisation or surgical procedure. Clinical diagnosis has been largely the primary diagnosing criterion for GBS along with electrodiagnosis, which has several pitfalls and is supported by ancillary testing of cerebrospinal fluid (CSF) analysis and Nerve Conduction Studies. Measurement of anti-ganglioside antibodies is also an effective tool in its diagnosis. Further understanding of pathophysiology and better diagnostic methods are required for better management of GBS.

1 September 1990 in Analytical Biochemistry
Verified
Journal Article
Closed access
PRPragna Rao
Pragna Rao
TPThillaisthanam N. Pattabiraman
Thillaisthanam N. Pattabiraman